(LFCR) – StreetInsider.com Reports
-
Lifecore Biomedical (LFCR) PT Lowered to $6 at Stephens
-
Lifecore Biomedical (LFCR) Announces Pending Change of Auditor and Provides Expectation for Business Update
-
Lifecore Biomedical (LFCR) Concludes Strategic Evaluation , Announces CEO Change
-
Lifecore Biomedical (LFCR) Completes Restatements and Files 10-K
-
Lifecore Biomedical (LFCR) Receives Nasdaq Delisting Notice, Intends to Appeal
-
Legion Partners Calls for Urgent Board Changes at The Chefs’ Warehouse (CHEF)
-
Lifecore Biomedical (LFCR) Expands Relationship with Existing Long-Term Customer
-
Lifecore Biomedical (LFCR) Issues Business Update
-
Lifecore Biomedical (LFCR) Receives Notice from Nasdaq Regarding Delayed Annual Report
-
Lifecore Biomedical (LFCR) Receives Notice from Nasdaq Regarding Delayed Annual Report
-
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.69%
-
Lifecore Biomedical (LFCR) Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Cust
-
Lifecore Biomedical (LFCR) Receives Nasdaq Delayed Report Notice
-
Lifecore Biomedical (LFCR) Sells Curation Foods’ O Olive Oil and Vinegar® Business
-
Stephens Downgrades Lifecore Biomedical (LFCR) to Equal Weight
-
Lifecore Biomedical (LFCR) Withdraws Fiscal 2023 Guidance
-
Lifecore Biomedical (LFCR) Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
-
Lifecore Biomedical (LFCR) to Explore Strategic Alternatives
-
Lifecore Biomedical (LFCR) Halted, News Pending
Back to LFCR Stock Lookup